Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2007;334:915 (5 May), doi:10.1136/bmj.39199.440104.3A
| The first 150 words of the full text of this article appear below. |
Marcus indicates the importance of candour in outlining the choices available to individuals.1 However, there is also the effect on wider issues of public health and the availability of treatment options from which patients can choose.
Unacceptable radiotherapy waiting times have been highlighted by the Royal College of Radiologists for over a decade.2 They have now started to improve, but the last audit in September 2005 still showed that over half our patients wait longer than one month for curative treatment. What is probably not made clear to patients is the impact that this can have on their prognosis. A systematic review has shown that for breast cancer a wait of longer than eight weeks carries a 60% increase in the risk of local recurrence over five years.3 For postoperative radiotherapy of head and neck cancer, a delay of six weeks increases the risk of local recurrence 2.6-fold.3
Worse than
Michael V Williams, dean, Faculty of Clinical Oncology
Royal College of Radiologists, London W1N 4JQ
michael_williams@rcr.ac.uk
Israeli students are refusing to perform intimate examinations on anaesthetised women without their informed consent.